Medtide

Parent company of CPC Scientific. Peptide CRDMO headquartered in Hangzhou, China, listed on the Hong Kong Stock Exchange (HKEX: 03880). Full-cycle peptide and oligonucleotide development and manufacturing services.

Medtide is listed as a CDMO in the peptide supply chain, serving Asia markets from China (Hangzhou). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.